Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Bone Marrow Derived Mesenchymal Stem Cells for Parkinson's Disease
NCT01446614Phase 2Unknown
- Sponsor
- General Hospital of Southern Theater Command of the People's Liberation Army
- Start
- Oct 2011
- Primary completion
- Jun 2013
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone-marrow mesenchymal stem cells in Parkinson's disease (PD), sponsored by General Hospital of Southern Theater Command of the People's Liberation Army. Status: unknown.
02
Drugs
autologous bone-marrow mesenchymal stem cells
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01446614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01446614.